Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion

American Academy of Allergy, Asthma, and Immunology, 2000 Dykewicz, 1998, Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology, Ann Allergy Asthma Immunol, 81, 478, 10.1016/S1081-1206(10)63155-9 Schoenwetter, 2000, Allergic rhinitis: epidemiology and natural history, Allergy Asthma Proc, 21, 1, 10.2500/108854100778248971 Sly, 1999, Changing prevalence of allergic rhinitis and asthma, Ann Allergy Asthma Immunol, 82, 233, 10.1016/S1081-1206(10)62603-8 Grossman, 1997, One airway, one disease, Chest, 111, 11S, 10.1378/chest.111.2_Supplement.11S Leynaert, 2000, Epidemiologic evidence for asthma and rhinitis comorbidity, J Allergy Clin Immunol, 106, S201, 10.1067/mai.2000.110151 Simons, 1999, Allergic rhinobronchitis: the asthma-allergic rhinitis link, J Allergy Clin Immunol, 104, 534, 10.1016/S0091-6749(99)70320-9 DuBuske, 1999, The link between allergy and asthma, Allergy Asthma Proc, 20, 341, 10.2500/108854199778251744 Welsh, 1987, Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy, Mayo Clin Proc, 62, 125, 10.1016/S0025-6196(12)61882-5 Corren, 1999, The relationship between allergic rhinitis and bronchial asthma, Curr Opin Pulm Med, 5, 35, 10.1097/00063198-199901000-00006 Agrawal, 2000, Desloratadine attenuation of eosinophil chemotaxis, adhesion, and superoxide generation, Allergy, 55, 276 Agrawal, 2001, Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug, Exp Opin Invest Drugs, 10, 547, 10.1517/13543784.10.3.547 Kreutner, 2000, Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects, Arzneimittelforschung, 50, 345 Meltzer, 2001, Efficacy and tolerability of once-daily 5 mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis: assessment during the spring and fall allergy seasons, Clin Drug Invest, 21, 25, 10.2165/00044011-200121010-00004 Horak, 2000, Onset and duration of action of desloratadine after controlled pollen challenges in patients with seasonal allergic rhinitis, Allergy, 55, 279 Lippert, 1995, Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist descarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines, Exp Dermatol, 4, 272, 10.1111/j.1600-0625.1995.tb00257.x Genovese, 1997, Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human FceRI+ cells, Clin Exp Allergy, 27, 559, 10.1111/j.1365-2222.1997.tb00745.x Lichtenstein, 2001, Inhibition of cytokine generation and mediator release in human basophils by desloratadine, J Allergy Clin Immunol, 107, S162 Fridericia, 1920, Die Systolendauer im Elektrokardiogramm bei normalen Menschen and bei Herzranken, Acta Med Scand, 52, 469 Fireman, 2000, Rhinitis and asthma connection: management of coexisting upper airway allergic diseases and asthma, Allergy Asthma Proc, 21, 45, 10.2500/108854100778248935 Reed, 1988, Effects of topical nasal treatment on asthma symptoms, J Allergy Clin Immunol, 81, 1042, 10.1016/0091-6749(88)90177-7 Nayak, 2001, Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis, Allergy, 56, 1077, 10.1034/j.1398-9995.2001.00082.x Horak F, Stubner P, Zieglmayer R, et al. Desloratadine reduces nasal congestion and maintains nasal airflow in patients with seasonal allergic rhinitis exposed to allergen in the Vienna Challenge Chamber. Poster presentation at the 20th Congress of the European Academy of Allergology and Clinical Immunology, 9-13 May 2001, Berlin, Germany. Simons, 1999, H1-receptor antagonists: safety issues, Ann Allergy Asthma Immunol, 83, 481, 10.1016/S1081-1206(10)62855-4 Marino, 2000, Lack of electrocardiographic effects of multiple high doses of desloratadine, Allergy, 55, 279 Affrime, 2000, Lack of electrocardiographic effects when desloratadine and ketoconazole are coadministered, Allergy, 55, 277 Glue, 2000, Lack of electrocardiographic interaction between desloratadine and erythromycin, Allergy, 55, 276 Gupta, 2001, Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study, Clin Ther, 23, 451, 10.1016/S0149-2918(01)80049-7 Cvetkovic, 1999, OATP and Pglycoprotein transporters mediate the cellular uptake and excretion of fexofenadine, Drug Metab Dispos, 27, 866 Dresser, 2001, Citrus juices are potent inhibitors of intestinal OATP but not P-glycoprotein, Clin Pharmacol Ther, 69, P23 Silverman, 2000, 135